Home Awards and Honors Media Placements Bridging the Cultural Gap Links Contact

News Archive

 

“Behind the Buzz” Show: FSD Pharma Inc. CEO & Co-Chairman Raza Bokhari

February 13th, 2020

FSD Pharma CEO, Dr. Raza Bokhari with Rebecca Urena on “Behind the Buzz” at BIO CEO & Investor Conference NYC states chronic inflammation is the subset of most diseases and we believe that through our lead compound, Micro PEA, we have a potential opportunity to create novel opioid sparing prescription medications that can help address the opioid crisis.

Click here to watch the video.

Email to a friend


FSD Pharma advancing its Phase 1 study in Australia

February 10th, 2020

Dr Raza Bokhari at BIO CEO & Investor Conference NYC, says Nucleus Network to conduct Phase 1 in human safety & tolerability study of FSD Pharma's lead candidate PP101 ultra micro PEA in Australia.

Click here to watch the video

Email to a friend


FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND

Sept 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari speaks about filing with the FDA an IND Application to initiate phase 2 clinical trial to treat hospitalized COVID-19 patients. 

Click here to watch the full video

FSD Pharma says $10M in new capital is 'gratifying' as the firm makes progress in coronavirus trial

August 10, 2020

FSD Pharma CEO, Dr. Raza Bokhari, on Proactive Investors spoke about completing US$10 million registered offering and provides progress  update on submitting IND Application to the FDA to use FSD201 to treat COVID-19 patients.

Click here to watch the full video

FSD Pharma – FDA Approval to Submit I.N.D. Application for Compound to Treat Covid-19 Patients

July 2, 2020

Dr Raza Bokhari, FSD Pharma CEO, talks about developing its ultra micro PEA Compound to treat COVID-19....

Click here to watch the video.

View Archive
Home | Awards and Honors | Media Placements | Bridging the Cultural Gap | Links | Contact © 2007 Dr. Raza Bokhari · All rights reserved.